-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cancer is already a "common disease" and even a "high incidence"According to the American Cancer Society, the lifetime cancer rate is 39.3 percent for men and 37.7 percent for womenHow to crack the cancer problem, change the "smell cancer color change, cancer despair" dilemma, has become the world's countries eager to crack the problemprecision cancer treatment to "smart"" cancer cells are the body's most "intelligent" cells, it is from normal cell cancer, when you want to kill it, it will show normal cell characteristics, and late-stage and early cancer cells in biological behavior is very different, these are the reasons why cancer is difficult to cureThe key to solving cancer, Yu Jinming says, is to start at the level of molecules, genes and cells, and to know exactly how each tumor molecule is mechanismed, the interactions between molecules, and the microenvironment"So the treatment of cancer is an individual ized system engineering of precision medicine, not a problem that a few doctors can solve when they sit together for a consultation, Jinming said, the vision of precision cancer treatment is to objectiveize subjective treatment, standardize objective treatment, personalize group therapy, precision personality therapy, and finally realize the digitalization of complex lifeAfter 2010, the rise of intelligent medicine, precision cancer treatment will certainly advance to "intellectual therapy", which requires molecular, anatomical imaging, artificial intelligence, big data and other multidisciplinary, multi-disciplinary, multi-disciplinary integration and cross-border integration, the precise development of personalized treatment equipment, technology and strategy" cancer treatment aims to achieve a precise, privately tailored treatment, rather than an anti-cancer drug that is available to people all over the worldYu Jinming pointed out that the specific process is to first based on the patient's tumor tissue and microenvironment to find potential targets, and then use next-generation gene sequencing (NGS), big data and other technologies to design personalized drugs, personalized ethics and clinical trials, to achieve personalized drug treatment"The resulting therapy is only effective for this patientimmunotherapy may be the most promising cure for cancer
radiotherapy, chemotherapy, surgery, targeted therapy and immunotherapy are the five treatments for cancer in the medical communityThe first three are traditional therapies, and the latter two are emerging therapiesin recent years, immunotherapy, represented by "CAR-T" technology, has made breakthroughs in the treatment of blood tumors, and two related drugs have been approved by the U.SFood and Drug Administration (FDA) for marketing Michel Sadelain, a professor at the Sloan Kettering Cancer Center, told the forum that the use of "CAR-T" technology is expanding from blood to solid tumors Yu Jinming believes that immunotherapy may be the most promising cure for cancer, but more need to be used with other therapies, hug warm At the same time, it also needs to cross-integrate with new technologies, integrated innovation, not only with precision medical integration into "precision immunity", to avoid no targeting, but also with artificial intelligence, big data and other integration into "digital immunity", in order to achieve the "immune plus" effect " nutritional therapy is the basis and premise of all anti-tumor therapy, such as surgery, radiotherapy, chemotherapy, etc., and is the first-line treatment of tumor patients "Professor Shi Hanping, Head of the Department of Oncology of Capital Medical University and founder of China's Oncology Nutrition Discipline, stressed at the forum that the anti-cancer treatment effect of malnourished tumor patients will be affected, and even cannot afford anti-cancer treatment, especially for patients with severe malnutrition such as esophageal cancer, to pay special attention to nutritional treatment In fact, malnourished people are also more likely to develop malignant tumors From a cancer prevention perspective, we should adhere to the "rich and varied diet, overeating, eating balance, physical and mental health" guidelines, and consciously increase protein intake " according to statistics, the five-year survival rate for cancer patients in China is 40%, compared with 70% in the United States We have gaps, but they are narrowing Yu Jinming pointed out that China's basic cancer research and clinical medicine is not much worse than others, and now the urgent need to strengthen clinical research, to promote the transformation of results from basic research to clinical medicine.